After several examples of undisclosed alterations in reagent suppliers’ antibody catalogues surfaced, researchers call for ...

Objective To investigate whether IgG to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens could reveal undetected SARS-CoV-2 exposure in a cohort of Malawian pregnant women ...

Hiba Therapeutics’ targeted biologics platform aims to address key solid tumor treatment challenges, while limiting systemic toxicity Grant provides access to MilliporeSigma's technologies, process ...

Through our partnership with Saturnus Bio, we aim to fast track the development of innovative therapies for genetic cardiomyopathies through precision cardiology, targeting the rare population ...

Merck KGaA, Darmstadt, Germany, a leading global science and technology company, today announced a strategic research-stage collaboration with Saturnus Bio, a Versant Ventures-founded biotech, aimed ...

Partnership builds on more than a decade of collaboration, reinforcing MilliporeSigma’s role in supporting the safe, reliable commercialization of novel modalities MilliporeSigma, the U.S. and Canada ...

WashU and MilliporeSigma, a pharmaceutical company affiliated with the multinational Merck Group, signed a formal non-binding agreement known as a Memorandum of Understanding (MoU) on July 24, 2025.

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Results of our annual survey of industry members are included, plus a deep look at safety in the Asia region and a product selection of stairs, lifts and boarding bridges. Feb. 13, 2025 Add Us On ...